Neoadjuvant Immune Checkpoint Inhibitors Plus Chemotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma: Perioperative and Survival Outcomes.
Frontiers in Oncology（2022）
Key words
esophageal squamous cell carcinoma,neoadjuvant therapy,immune checkpoint inhibitor,esophagectomy,perioperative outcomes,survival outcomes
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined